Recent in North America (page 15 of 16)

OPI Pressured to Make Over Nail Polish Formulas

A coalition delivering letters to nail salons that sell OPI nail products is urging salons to sell safer brands of nail polish.

Ingredient Review Update from CTFA

The Cosmetic Ingredient Review (CIR) board announced updated ingredient assessments in its April 4, 2006, report.

Regulatory Review--United States and Canada: Update Online

Methods of registering cosmetic formulations are changing. This column will desribe the online registration processes for the United States and Canada.

Exclusive! Comparatively Speaking: Drugs vs. Cosmetics by Tony O'Lenick

Tony O’Lenick asks: What is the difference between a drug and cosmetic? David Steinberg explains.

CTPA Says Review Paper on AP/Deo, Breast Cancer Should Not Cause Alarm

A recent paper calling for further research into the alleged link between aluminium salts in antiperspirants and breast cancer should not constitute alarm, said the CTPA.

AAD Responds to FDA Labeling Decision on Eczema Medications
[Feb. 21, 2006]

The American Academy of Dermatology (AAD) recently issued a statement in response to the U.S. Food and Drug Administration’s (FDA) decision that a black box warning be added to labels...

FDA Commissions Study of its Drug, Biologics Application Processes

The U.S. Food and Drug Administration (FDA) released a new report that examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.

Dermatology Association Urges FDA to Postpone Program for Isotretinoin Patients

Patient safety while taking isotretinoin depends on the careful oversight of the prescriber, according to the American Academy of Dermatology Association.

Regulatory Review--United States Update

California’s Safe Cosmetic Act Well, he did it. In October Governor Arnold Schwarzenegger signed into law the California Safe Cosmetic Act of 2005. As reported in my last column, this new law will not make cosmetics safer than they are now, but will increase costs for cosmetic companies and the taxpayers of the State of California while accomplishing absolutely nothing.

Canada Updated

At the December 2003 Society of Cosmetic Chemists annual meeting, I presented a one-day session on international cosmetic regulations, and concluded by saying that 2004 would be the year of Canada. So far in 2004, three major changes have occurred.

California Update

On August 26, 2004, the entire cosmetic industry dodged a bullet--or rather, Armageddon–by a single vote. The California Assembly rejected a bill that would have prohibited California companies from making or selling cosmetic/personal care items that contain phthalates and other ingredients considered under this law as toxic. The vote was 4 in favor, 5 opposed and 10 others either abstained or weren’t present.

Implementing 21 CFR Part 11 in Cosmetics

21 CFR Part 11 specifies the comprehensive set of administrative, procedural and technical controls that must be implemented when data files, records and signatures are created, maintained or archived in an electronic format as part of a program to comply with FDA rules. In the cosmetics industry, specific applications are in development and testing of OTC drugs and color additives.

Can't find what you're looking for? Try searching, or looking through past issues.